DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis
Pauline Howell, Robert S. Wallis, Nestani Tukvadze, Elena Tudor et al.
Citations
3 citations
Journal
BMC Infectious Diseases
Topics
Tuberculosis Research and Epidemiology
Field-Weighted Citation Impact (FWCI)
4.19
article
DRTB-HDT: a randomized controlled trial of two adjunctive host-directed therapies in rifampin-resistant tuberculosis
Pauline Howell, Robert S. Wallis, Nestani Tukvadze, Elena Tudor, Annelies Van Rie, Valeriu Crudu, Celso Khosa, Kogieleum Naidoo, Stefan Niemann, Anne K. Jacobs, Norbert Heinrich, Klaus Reither, Elmira Ibraim, Leila Goginashvili, Shakira Rajaram, Tlhago Ngwanto, Sehlomola Mashatole
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC Infectious DiseasesVol. 25(1)
Institutions
University of Antwerp (BE), Swiss Tropical and Public Health Institute (CH), University of Basel (CH), German Center for Infection Research (DE), Aurum Institute (ZA), National Center for Tuberculosis and Lung Disease (GE), Institutul de Pneumoftiziologie "Marius Nasta" (RO), Africa Health Research Institute (ZA), Research Center Borstel - Leibniz Lung Center (DE), Instituto Nacional de Saúde (MZ), Case Western Reserve University (US), Ludwig-Maximilians-Universität München (DE)
Funders
Universität Basel, European Commission, Universiteit Stellenbosch, Horizon 2020 Framework Programme